ObjectiveTo explore the potential for community pharmacist prescribing in terms of
usefulness, pharmacists’ confidence, and appropriateness, in the context of
asthma management. MethodsTwenty community pharmacists were recruited using convenience sampling from a
group of trained practitioners who had already delivered asthma services.
These pharmacists were asked to complete a scenario-based questionnaire (9
scenarios) modelled on information from real patients. Pharmacist
interventions were independently reviewed and rated on their appropriateness
according to the Respiratory Therapeutic Guidelines (TG) by three expert
researchers.ResultsIn seven of nine scenarios (78%), the most common prescribing intervention
made by pharmacists agreed with TG recommendations. Although the prescribing
intervention was appropriate in the majority of cases, the execution of such
interventions was not in line with guidelines (i.e. dosage or frequency) in
the majority of scenarios. Due to this, only 47% (76/162) of the
interventions overall were considered appropriate. However, pharmacists were
deemed to be often following common clinical practice for asthma
prescribing. Therefore 81% (132/162) of prescribing interventions were
consistent with clinical practice, which is often not guideline driven,
indicating a need for specific training in prescribing according to
guidelines. Pharmacists reported that they were confident in making
prescribing interventions and that this would be very useful in their
management of the patients in the scenarios.ConclusionsCommunity pharmacists may be able to prescribe asthma medications
appropriately to help achieve good outcomes for their patients. However,
further training in the guidelines for prescribing are required if
pharmacists are to support asthma management in this way.